Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Department of Human Services. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Department of Human Services may be obtained either by posting an Authority Prescription Form to Department of Human Services, or by using Department of Human Services' Authority Freecall service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

Legend
MP
Medical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 5602W ABACAVIRabacavir 20 mg/mL oral liquid, 240 mL 8 8 5
MP 5601T ABACAVIRabacavir 300 mg tablet, 60 2 120 5
MP 5603X ABACAVIR + LAMIVUDINEabacavir 600 mg + lamivudine 300 mg tablet, 30 2 60 5
MP 5604Y ABACAVIR + LAMIVUDINE + ZIDOVUDINEabacavir 300 mg + lamivudine 150 mg + zidovudine 300 mg tablet, 60 2 120 5
MP 5605B ABATACEPTabatacept 250 mg injection, 1 x 250 mg vial 1 1 0
MP 9661L ADALIMUMABadalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes 1 2 0
MP 9663N ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges 1 2 0
MP 9662M ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes 1 2 0
MP 5606C ADEFOVIR DIPIVOXILadefovir dipivoxil 10 mg tablet, 30 2 60 5
MP 5608E AMBRISENTANambrisentan 10 mg tablet, 30 1 30 0
MP 5607D AMBRISENTANambrisentan 5 mg tablet, 30 1 30 0
MP 5609F APOMORPHINEapomorphine hydrochloride 20 mg/2 mL injection, 5 x 2 mL ampoules 72 360 5
MP 5611H APOMORPHINEapomorphine hydrochloride 50 mg/10 mL injection: subcutaneous infusion, 5 x 10 mL syringes 36 180 5
MP 5610G APOMORPHINEapomorphine hydrochloride 50 mg/5 mL injection, 5 x 5 mL ampoules 36 180 5
MP 5613K ATAZANAVIRatazanavir 150 mg capsule, 60 2 120 5
MP 5614L ATAZANAVIRatazanavir 200 mg capsule, 60 2 120 5
MP 5612J ATAZANAVIRatazanavir 300 mg capsule, 30 2 60 5
MP 9597D AZACITIDINEazacitidine 100 mg injection, 1 x 100 mg vial 14 14 2
MP 9598E AZACITIDINEazacitidine 100 mg injection, 1 x 100 mg vial 14 14 5
MP 5616N AZITHROMYCINazithromycin 600 mg tablet, 8 2 16 5